Uncategorized
Conjunctivitis test granted CLIA waiver
An improved version of a first-point-of-care diagnostic test for conjunctivitis (AdenoPlus, Rapid
Pathogen Screening [RPS]) has been granted waived status by the FDA under the Clinical Laboratory Improvement
Amendments (CLIA).